biliary tract tumors
Conditions
Interventions
two:Bevacizumab
Sponsors
The Afiliated Tumor Hospital of Xinjiang Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) all of the patients were biliary tumor, have definite pathological diagnosis; (2) the tumor stage of late, no operative indications; (3) there are imaging evaluation of solid tumors tumors had the smallest > 2 cm in diameter; (4) ECOG score of 0 to 2 points; (5) main organs function before TACE evaluation tolerated intervention local chemotherapy.
Exclusion criteria
Exclusion criteria: (1) total bilirubin > 200 umol/L; (2) a history of gastrointestinal bleeding, 1 month except tumor hemorrhage; (3) in situ stove is not obvious, the simple lymph node metastasis; (4) Serious coagulation dysfunction is not correct; (5) refractory ascites; (6) disturbance of consciousness, cant cooperate with treatment; (7) the obvious evil fluid to pledge. (8) In recent three years with the second malignant tumor, patients suffering gall bladder tumor, at the me time the extrahepatic bile duct tumor or intrahepatic bile duct cancer, as the me kind of tumor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease control rates;Overall survival; | — |
Countries
China
Contacts
Public ContactWukui Huang
Outcome results
None listed